These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29150289)

  • 1. The cause of multiple sclerosis is autoimmune attack of adenosyltransferase thereby limiting adenosylcobalamin production.
    Boucher JL
    Med Hypotheses; 2017 Nov; 109():29-37. PubMed ID: 29150289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ATP:Cob(I)alamin adenosyltransferase and its interaction with methionine synthase reductase.
    Leal NA; Olteanu H; Banerjee R; Bobik TA
    J Biol Chem; 2004 Nov; 279(46):47536-42. PubMed ID: 15347655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rotary mechanism for coenzyme B(12) synthesis by adenosyltransferase.
    Padovani D; Banerjee R
    Biochemistry; 2009 Jun; 48(23):5350-7. PubMed ID: 19413290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of allostery and coenzyme B12 delivery by a pathogenic mutation in adenosyltransferase.
    Lofgren M; Banerjee R
    Biochemistry; 2011 Jun; 50(25):5790-8. PubMed ID: 21604717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple roles of ATP:cob(I)alamin adenosyltransferases in the conversion of B12 to coenzyme B12.
    Mera PE; Escalante-Semerena JC
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):41-8. PubMed ID: 20677021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional genomic, biochemical, and genetic characterization of the Salmonella pduO gene, an ATP:cob(I)alamin adenosyltransferase gene.
    Johnson CL; Pechonick E; Park SD; Havemann GD; Leal NA; Bobik TA
    J Bacteriol; 2001 Mar; 183(5):1577-84. PubMed ID: 11160088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-ordinate variations in methylmalonyl-CoA mutase and methionine synthase, and the cobalamin cofactors in human glioma cells during nitrous oxide exposure and the subsequent recovery phase.
    Riedel B; Fiskerstrand T; Refsum H; Ueland PM
    Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):133-8. PubMed ID: 10377254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells in multiple sclerosis.
    Wekerle H
    Autoimmunity; 2017 Feb; 50(1):57-60. PubMed ID: 28166681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].
    Jaśkiewicz E
    Postepy Hig Med Dosw (Online); 2004; 58():472-82. PubMed ID: 15765008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.
    de Rosbo NK; Ben-Nun A
    J Autoimmun; 1998 Aug; 11(4):287-99. PubMed ID: 9776706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis and air pollution exposure: Mechanisms toward brain autoimmunity.
    Esmaeil Mousavi S; Heydarpour P; Reis J; Amiri M; Sahraian MA
    Med Hypotheses; 2017 Mar; 100():23-30. PubMed ID: 28236843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple sclerosis: etiology and pathogenesis].
    Zavalishin IA; Zakharova MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; (Spec No 2):10-7. PubMed ID: 12938629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A view for understanding the pathogenesis of multiple sclerosis].
    Tabira T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1493-5. PubMed ID: 8752441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High resolution melting analysis of the MMAB gene in cblB patients and in those with undiagnosed methylmalonic aciduria.
    Illson ML; Dempsey-Nunez L; Kent J; Huang Q; Brebner A; Raff ML; Watkins D; Gilfix BM; Wittwer CT; Rosenblatt DS
    Mol Genet Metab; 2013; 110(1-2):86-9. PubMed ID: 23707710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E
    Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.
    Sun J; Link H; Olsson T; Xiao BG; Andersson G; Ekre HP; Linington C; Diener P
    J Immunol; 1991 Mar; 146(5):1490-5. PubMed ID: 1899688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.
    Sun JB; Olsson T; Wang WZ; Xiao BG; Kostulas V; Fredrikson S; Ekre HP; Link H
    Eur J Immunol; 1991 Jun; 21(6):1461-8. PubMed ID: 1710567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for adenosylcobalamin activation in AdoCbl-dependent ribonucleotide reductases.
    Larsson KM; Logan DT; Nordlund P
    ACS Chem Biol; 2010 Oct; 5(10):933-42. PubMed ID: 20672854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deleterious versus protective autoimmunity in multiple sclerosis.
    Kostic M; Stojanovic I; Marjanovic G; Zivkovic N; Cvetanovic A
    Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.